On March 15, 2021, the FDA issued a Warning Letter to EU Natural Inc., a Florida-based supplement brand selling through Amazon and its own DTC site. The letter cited nine product pages for disease claims linking the brand's turmeric, elderberry, and mushroom supplements to the treatment or prevention of specific diseases.[1]
EU Natural responded. And then, over the next fourteen months, the brand quietly rewrote its entire public-facing product copy. We tracked every change.
Five years later, the pre-letter language still surfaces in AI engine answers. The brand cleaned its own house. It could not clean the internet.
What the letter cited
The Warning Letter quoted nine phrases drawn from six product pages. Three examples capture the range:
Each phrase named a disease and linked it to a specific product ingredient. Under DSHEA, these are textbook disease claims, prohibited for dietary supplements absent a new drug application.[2]
The fourteen-month rewrite
We began monitoring EU Natural's product pages in April 2021, one month after the Warning Letter was issued. We captured snapshots monthly through June 2022. The edits came in three distinct waves.
Wave 1: Immediate removals (April-May 2021). The most aggressive disease language disappeared within six weeks. "Alzheimer's," "dementia," "influenza," and "heart disease" were deleted from all product pages. After Wave 1, the six cited pages contained zero named diseases.
Wave 2: Structure-function migration (June-October 2021). EU Natural did not simply delete the claims. The brand rewrote them, converting disease language into structure-function language. The conversions were precise:
- "Reduce inflammation associated with arthritis" became "supports a healthy inflammatory response."
- "Fight off colds and flu" became "supports immune system function during seasonal changes."
- "Preventing the onset of dementia" became "supports cognitive function and mental clarity."
- "Reduce the duration and severity of influenza" became "supports the body's natural immune defenses."[3]
Every conversion followed the same pattern: remove the disease name, keep the body system, add "supports" as the operative verb. The word "supports" appeared on EU Natural's product pages approximately 34 times after Wave 2, up from 11 times before the Warning Letter.
A note on the "seasonal changes" phrasing: in 2021, this migration was considered compliant. It avoids naming specific diseases (no "cold," no "flu," no "influenza"). But as we covered in our analysis of the Sunshine Botanicals Warning Letter (Post 2 in this series), temporal and seasonal framing has come under new scrutiny since early 2026. The key distinction: "during cold and flu season" names diseases and crosses the line. "During seasonal changes" does not name diseases and sits in safer territory, though the engines are now drawing the boundary wider than the FDA has. EU Natural's 2021 conversion was sound by 2021 standards. Whether it would be as safe in 2026 is an open question.
Wave 3: Quiet disappearances (November 2021-June 2022). Several claims neither survived nor migrated. They simply vanished. The Lion's Mane product page went from four paragraphs of health claims to two. The deleted paragraphs discussed nerve regeneration and neuroprotective effects. They were cut entirely, not rewritten.
Those quiet disappearances matter most. They represent claims that were neither preserved nor rewritten. The observable result: the brand removed them entirely rather than attempting a structure-function conversion. That restraint is rare. Most brands try to save every claim.
Final tally across all six cited product pages: of the original 42 health-related phrases, 9 were deleted in Wave 1, 18 were migrated to structure-function language in Wave 2, 8 quietly disappeared in Wave 3, and 7 survived untouched because they were already compliant.
The brand did not hire a compliance team and rewrite everything overnight. It edited one sentence at a time, over fourteen months, making judgment calls about which phrases could be saved and which had to go. EvidenceSignal Research
What the engines see now
EU Natural's rewrite was successful by one measure: no second Warning Letter. As of May 2026, its product pages contain no disease claims that would trip our DSHEA classifier.
But the pre-2021 language is not gone from the internet. It lives in cached pages, in affiliate blog posts that copied the original descriptions verbatim, and in the training data of the AI engines themselves.
We tested this. The query "does EU Natural turmeric help with arthritis?" returns different answers by engine. ChatGPT references turmeric's anti-inflammatory properties generally but does not link EU Natural's product to arthritis. Claude similarly avoids the disease connection.
Perplexity is another story. It pulls from a 2021 blog post on a third-party review site that still contains the original, pre-letter language: "EU Natural's turmeric has been shown to reduce inflammation associated with arthritis." That blog post was never updated. Perplexity cites it as a source.[4]
The brand cleaned its own pages. It cannot clean the internet.
The compliance tail
This is the pattern we see across the supplement-related Warning Letters in our FDA corpus. The brand's own pages get cleaned up. But the original language persists in affiliate content, review sites, Amazon Q&A sections, and cached results.
Before AI engines, that persistence was a minor nuisance. Now the engines aggregate those secondary sources into synthesized answers. A single uncorrected affiliate blog post can become the source for a response seen by thousands of people. EU Natural spent fourteen months fixing its own copy. Five years later, the pre-fix language still surfaces on Perplexity. The compliance tail is measured in years, not months.[5]
Two lessons from a small brand's long edit
First, structure-function migration is a skill, not a checkbox. EU Natural's Wave 2 conversions were well done. "Supports a healthy inflammatory response" is meaningfully different from "reduces inflammation associated with arthritis." Many brands do this badly, producing structure-function language that still implies a disease claim.
Second, cleaning your own pages is necessary but not sufficient. Any brand that has ever published disease-adjacent language should assume that original copy is still circulating in AI training data and secondary sources. Monitoring what the engines say about your brand is now a permanent line item, not a one-time project.
Footnotes
- FDA Warning Letter to EU Natural Inc., March 15, 2021. Issuing office: CFSAN. The letter cited violations of 21 U.S.C. 343(r)(6) and 21 U.S.C. 331(a). Full text available in the FDA's Warning Letters database.
- Under DSHEA (1994), dietary supplement labels and marketing may include structure-function claims ("supports immune health") with an FDA disclaimer, but may not include disease claims ("treats influenza") without an approved NDA. The distinction turns on whether the claim references a specific disease by name or implication.
- All phrase comparisons are drawn from EvidenceSignal's monthly snapshots of EU Natural's product pages, captured via Wayback Machine and our own archival pipeline. Exact capture dates available on request.
- The third-party blog post in question was published in February 2021, before the Warning Letter was issued. It has not been updated since. We are not naming the blog to avoid directing traffic to non-compliant content. Capture date: May 12, 2026.
- Of the 223 supplement-related Warning Letters in our FDA corpus, we have tracked post-letter copy changes for 31 supplement brands. The median time to full compliance on owned pages was 5.2 months (n=31). The median time for secondary-source language to stop appearing in AI engine responses has not yet been reached for any of the 31, as of May 2026. Full methodology at /methodology.